IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic laser systems, delivery devices, and consumable instrumentation to treat vision-threatening eye diseases in ophthalmology. The company is headquartered in Mountain View, California.
| Revenue (TTM) | $52.58M |
| Gross Profit (TTM) | $18.91M |
| EBITDA | $-2.47M |
| Operating Margin | -2.75% |
| Return on Equity | -56.50% |
| Return on Assets | -5.38% |
| Revenue/Share (TTM) | $3.08 |
| Book Value | $-0.06 |
| Price-to-Book | 331.20 |
| Price-to-Sales (TTM) | 0.33 |
| EV/Revenue | 0.444 |
| EV/EBITDA | -3.61 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -0.80% |
| Shares Outstanding | $17.41M |
| Float | $11.41M |
| % Insiders | 28.92% |
| % Institutions | 18.04% |
Volatility is currently expanding